Evidence map›Paper›PMID 42108421›Full record

ArticleJournal of cellular and molecular medicine2026

Integrated Bulk and Single-Cell RNA-Seq Analysis Reveals Transcriptional Activation of PTGS2 by FOS in Progression From T2DM to T2DM-Associated NAFLD.

Rong Lin, Leqin Xu, Yi Zhou, Yanjing Fan, Huan Xie, Wanzhang Li, Tianchi Hu, Chao Liu

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rong LinDepartment of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine for Nanjing University of Chinese Medicine, Nanjing, China.
Leqin XuXiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Yi ZhouDepartment of Endocrinology, Xiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Yanjing FanDepartment of Endocrinology, Xiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Huan XieDepartment of Endocrinology, Xiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Wanzhang LiDepartment of Endocrinology, Xiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Tianchi HuDepartment of Endocrinology, Xiamen Hospital of Traditional Chinese Medicine (Xiamen Hospital, Beijing University of Chinese Medicine), Xiamen, China.
Chao LiuDepartment of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine for Nanjing University of Chinese Medicine, Nanjing, China.ORCID 0009-0002-5069-877X

Funding

the Natural Science Foundation of Xiamen, China 3502Z20227356
6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) frequently coexist, exacerbating disease burden. However, the molecular mechanisms underlying the progression from T2DM to T2DM-associated NAFLD remain unclear. This study investigated the regulatory function of FOS-mediated PTGS2 activation in this transition. We integrated bulk RNA-seq data from GEO, single-cell transcriptomic data and transcriptomes from patients with T2DM-associated NAFLD. Differentially expressed genes were identified using the limma package, and T2DM-related gene modules were defined by weighted gene co-expression network analysis. LASSO regression and random forest identified 14 candidate genes, with PTGS2 and FOS prioritised. Single-cell analysis showed increased FOS and PTGS2 expression in monocytes, CD8

Indexed as

Cyclooxygenase 2Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseProto-Oncogene Proteins c-fosTranscriptional ActivationAdultCell LineDisease ProgressionFemaleGene Expression RegulationHepatocytesHumansMaleMiddle AgedPromoter Regions, GeneticSingle-Cell Gene Expression AnalysisCyclooxygenase 2FOS protein, humanProto-Oncogene Proteins c-fosPTGS2 protein, humanapoptosisbiomarkersFOSinflammationnonalcoholic fatty liver diseasePTGS2type 2 diabetes mellitus

Identifiers

PMID42108421
PMCPMC13158135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.